Impact of beta-blockers on prognostic outcomes in solid cancers: a systematic review and meta-analysis

医学 观察研究 系统回顾 内科学 肿瘤科 肺癌 重症监护医学 癌症 科克伦图书馆 总体生存率 荟萃分析 梅德林 存活率 生存分析 相对存活率 实体瘤 癌症存活率 重新调整用途
作者
S Eraslan,Emine Ceren Ayhan,Michael Tvilling Madsen,Erica K. Sloan,Ismail Gögenur,Adile Orhan
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
被引量:3
标识
DOI:10.1093/jnci/djag082
摘要

BACKGROUND: Beta-blockers are conventionally prescribed for cardiovascular indications and have potential for repurposing in oncology as adrenergic signalling promotes cancer progression. This systematic review and meta-analysis evaluated whether beta-blocker use is associated with improved survival outcomes in patients with all stages of solid cancer. METHODS: This systematic review and meta-analysis was conducted in accordance with PRISMA guidelines using a predefined (PICO) framework. Four databases (PubMed, Embase, Cochrane Library, and Web of Science) were searched. Eligible studies compared beta-blocker users with non-users and reported survival outcomes in patients with solid cancer. Outcomes included overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), progression-free survival (PFS) and recurrence-free survival (RFS). Risk of bias was assessed using the Newcastle-Ottawa Scale (NOS) and the Cochrane Risk of Bias 2 tool. Certainty of evidence was evaluated using GRADE. RESULTS: A total of 5122 articles were screened; 94 articles were included in the systematic review and 84 in the meta-analysis comprising 603,827 patients. Beta-blocker use in patients with solid cancers was associated with significantly improved OS (HR 0.88, 95% CI: 0.80-0.96) and PFS (HR 0.82, 95%CI: 0.69-0.97). The greatest effects on OS were observed in patients with gastrointestinal (HR 0.84, 95%CI: 0.72-0.98), lung (HR 0.84, 95%CI: 0.71-0.99), and skin cancers (HR 0.81, 95%CI: 0.73-0.89). Effects appeared stronger with post-diagnostic exposure and in certain cancer subtypes, however, heterogeneity and the observational nature of most included studies warrant cautious interpretation. CONCLUSION: Beta-blocker use was associated with improved OS and PFS in patients with solid cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
郭郭发布了新的文献求助10
刚刚
刚刚
搜集达人的应助被lukou采纳,获得100
刚刚
刚刚
星辰大海的应助被Wen采纳,获得10
1秒前
1秒前
xiao完成签到 ,获得积分10
1秒前
XXKK完成签到,获得积分10
1秒前
星1993发布了新的文献求助10
1秒前
淡淡幻柏发布了新的文献求助10
1秒前
2秒前
2秒前
无辜静枫完成签到,获得积分10
2秒前
qin202569发布了新的文献求助10
2秒前
3秒前
zzk发布了新的文献求助10
3秒前
ccccc发布了新的文献求助10
3秒前
3秒前
丘比特的应助被Dction采纳,获得10
3秒前
3秒前
钟梓袄发布了新的文献求助30
3秒前
CipherSage的应助被温暖砖头采纳,获得10
4秒前
4秒前
4秒前
4秒前
六七完成签到 ,获得积分10
4秒前
xxx完成签到 ,获得积分10
4秒前
5秒前
天赐殊荣发布了新的文献求助10
5秒前
Jay发布了新的文献求助10
5秒前
5秒前
科研通AI65的应助被云翳采纳,获得10
6秒前
6秒前
OrangeLight完成签到,获得积分10
6秒前
冷水完成签到,获得积分10
6秒前
6秒前
wesley完成签到 ,获得积分10
6秒前
7秒前
英俊的铭的应助被xianggua采纳,获得10
7秒前
情怀的应助被corleeang采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124